The European Commission has issued its inaugural progress report on the EU CO₂ injection capacity target set under Regulation (EU) 2024/1735, the Net-Zero Industry Act (NZIA)......
Commission launches call for feedback on draft guidelines for trusted flaggers The European Commission is seeking input and comments on provisional guidance concerning trusted flaggers under the EU Digital Services Act. Trusted flaggers are organisations with expertise in detecting unlawful content online......
In this issue: EU fundamentals Competition and state aid Data protection and cybersecurity Financial services Environment Life sciences Regulatory TMT International trade Daily and weekly news alerts New and updated content Trackers and horizon scanners EU fundamentals Commission launches call for evidence on citizens omnibus initiative The Commission has opened a call for evidence on a planned Citizens Omnibus Initiative, intended to cut red tape in EU laws and policies that affect those lawfully living in the EU, with a focus on cross-border scenarios. Scheduled for adoption in the final quarter of 2026, the proposal seeks to streamline rules, remove legal and administrative obstacles and enhance access to single market advantages via targeted tweaks to current legislation. The Commission has highlighted areas ripe for simplification, such as cross-border...
Temu received a €200 million penalty from the European Commission under the EU Digital Services Act for failing to adequately identify, analyse and evaluate the systemic risks tied to illegal goods on its platform and the consequent harm caused to consumers across the EU......
The life sciences arena spans companies in pharmaceuticals, biotechnology and medical technology, all dedicated to the research, development and commercialisation of a broad range of products with a medical purpose.
These include:
As you would expect, the sector is tightly regulated, and taking products from development through to commercialisation is subject to strict requirements. There is no single, neatly defined body of “pharmaceutical” or “life sciences” law; instead, a complex framework drawn from multiple sources applies. Within the EU, much of the regime arises from Directives or Regulations, supported by guidance issued by the European Commission and the European Medicines Agency (EMA), the EU’s decentralised agency responsible for the scientific evaluation, supervision and safety monitoring of medicines.
Article 2(1) of Regulation (EU) 2017/745, the Medical Devices Regulation (MDR), describes a medical device as any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to...
When evaluating a general damages claim, the practitioner ought initially to refer to the Judicial College Guidelines (JCG)...
This Practice Note This Practice Note reviews mechanisms used in settling litigation. A Tomlin order consists of a consent order paired with a schedule. It operates to stay proceedings on terms that have been agreed. The provisions contained in the schedule may remain confidential. This Practice Note describes the scope of confidentiality attaching to the schedule and sets out how it differs from a standard consent order. Sample wording for a Tomlin order is included, alongside links to precedents, as well as guidance on court approval. It also addresses varying, setting aside and enforcing a Tomlin order, including the considerations the court will take into account when handling applications for each. Further guidance is provided on interpreting and applying the relevant provisions of the CPR; however, some courts and divisions impose very specific requirements for both drafting and approval, and for approaching the schedule and confidentiality issues. Accordingly, you must consider the particular rules and court guide provisions in the forum where your claim is proceeding when drawing up the Tomlin order...
Date [ date ] Parties [ name of Landlord ] [ of OR incorporated in England and Wales (company registration number [ number ]) with its registered office at ] [ address ] (Landlord) [ name of Tenant ] [ of OR incorporated in England and Wales (company registration number [ number ]) with its registered office at ] [ address ] (Tenant) [ [ name of Guarantor ] [ of OR incorporated in England and Wales (company registration number [ number ]) with its registered office at ] [ address ] (Guarantor) ] [ [ name of Mortgagee ] [ of OR incorporated in England and Wales (company registration number [ number ]) with its registered office at ] [ address ] (Mortgagee) ] Definitions Within this Deed, the terms below shall be interpreted as follows: [ Annual Rent • the annual sum reserved under the Lease; ] [ Insurance Rent • the Tenant’s share of the Landlord’s costs of insuring the Property (as set out in the Lease); ] Lease • the lease of the Property dated [ date ], entered into between (1) [ the Landlord OR [ name ...
I, [ name ], of [ address ], solemnly and sincerely state that: [ Matters to be verified, set out in numbered paragraphs ] I make this solemn statement in good conscience, believing it to be true, and pursuant to the provisions of the Statutory Declarations Act 1835. DECLARED at [ details ] this [ day ] day of [ month and year ] Before me ................................................................................ [ signature of the person before whom the declaration is made ] A [ commissioner for oaths OR [ solicitor OR [ insert other qualification ] ] authorised to administer oaths ]...